Monday April 22, 2013
Amgen, Inc., a California-based biotechnology company, has agreed to pay the United States $24.9 million to settle allegations that it violated the False Claims Act for marketing Aranesp to treat anemia in nursing home residents.
Friday May 25, 2012
For more than 20 years, the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults has been the leading source of information about the safety of prescribing drugs for older people. To help prevent medication side effects and
Monday April 23, 2012
It has been recently noted after review of numerous medical records a common trend has been identified. Residents with impaired cognition are exhibiting behaviors i.e. screaming out, resisting care, removing clothes etc. The residents are being assessed for behavioral interventions
Wednesday May 4, 2011
Report: OEI-07-08-00150 05-04-2011 For the period January 1 through June 30, 2007, we determined using medical record review that 51 percent of Medicare claims for atypical antipsychotic drugs were erroneous, amounting to $116 million. A member of Congress requested that